Meningioma Clinical Trials in San Francisco, California

4 studies are recruiting for meningioma in San Francisco, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma

    This clinical trial tests the safety and effectiveness of hypofractionated stereotactic radiosurgery for treating patients who have undergone surgical resection for grade II meningiomas or grade I meningiomas that have come back after a period of improvement (recurrent). Radiation therapy uses high…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of California, San Francisco, San Francisco, California
    Run by
    University of California, San Francisco

    See if you can join NCT06557512 on ClinicalTrials.gov

  2. Feasibility of Acquiring Hyperpolarized Imaging in Patients With Meningioma

    This is a Pilot/Phase I clinical study of hyperpolarized 13C (HP 13C) pyruvate injection that includes the acquisition of magnetic resonance (MR) data performed on participants with meningioma to evaluate metabolism and aid in the non-invasive characterization of aggressive tumor behavior

    Stage
    Phase 1
    Ages
    18 and older
    Site
    University of California, San Francisco, San Francisco, California
    Run by
    Charlie Wang, MD, PhD

    See if you can join NCT06014905 on ClinicalTrials.gov

  3. A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma

    This study will recruit participants with Grade 2 and 3 meningiomas who have failed prior therapy. Participants will receive oral doses of JZP3507. The antitumor activity and safety of JZP3507 will be evaluated.

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Sutter Health, San Francisco, California
    Locations
    5 in total
    Run by
    Jazz Pharmaceuticals

    See if you can join NCT07533942 on ClinicalTrials.gov

  4. Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma

    Meningiomas are the most common primary brain tumor, and some groups are diagnosed with higher-grade tumors and have clinically worse outcomes. This study investigates social determinants of health and individual risk factors that may be associated with meningioma.

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of California San Francisco, San Francisco, California
    Run by
    University of California, San Francisco

    See if you can join NCT07418775 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.